Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03719001Phase 1Completed
Phase 1, open-label trial (6 arms), sponsored by University of California, San Francisco. Primary endpoint: Amplitude and/or frequency of myogenic oscillations up to 5 minutes. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03719001.